Sintx Technologies (NASDAQ:SINT) Posts Earnings Results, Misses Expectations By $0.02 EPS

Sintx Technologies (NASDAQ:SINT) posted its quarterly earnings data on Tuesday. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.73) by ($0.02), FiscalAI reports. The business had revenue of $0.45 million during the quarter, compared to analyst estimates of $0.46 million. Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 428.34%.

Here are the key takeaways from Sintx Technologies’ conference call:

• Revenue and margins improved substantially: Second-quarter revenue rose 199% year over year to $452,000, while product revenue increased 347% and gross margin expanded to 61.5% from 37.7%. Management cautioned that the gains came from a small base and margins may vary by product mix and manufacturing efficiency.
• SINTX reported purchase orders exceeding $3.2 million from existing contract-manufacturing customers, with production and shipments beginning and expected to continue into 2027. The company emphasized that converting these orders into recognized revenue will depend on production, quality release, shipment timing, customer acceptance, and cash collection.
• The SINAPTIC Foot and Ankle Osteotomy Wedge System generated initial commercial revenue after its first U.S. clinical use, but broader adoption remains dependent on surgeon education, distribution, product availability, reimbursement considerations, and market development.
• Liquidity remains a major risk: SINTX ended the quarter with $3.6 million in cash, used $5.3 million in operating cash during the first half, and disclosed substantial doubt about its ability to continue as a going concern. Management expects to pursue additional equity and/or debt financing despite approximately $5.1 million of remaining ATM capacity.
• The company continues to operate at a loss, with a second-quarter net loss of $2.7 million and first-half net loss of $5.5 million, while operating expenses increased 16% year over year. Management is evaluating staffing, facilities, outside services, inventory, and other costs as it works to align spending with commercial returns.

Sintx Technologies Price Performance

Shares of NASDAQ SINT traded up $0.11 during midday trading on Thursday, hitting $1.68. 102,302 shares of the company’s stock were exchanged, compared to its average volume of 66,254. The stock’s 50 day moving average price is $1.81 and its 200-day moving average price is $2.37. The firm has a market cap of $7.25 million, a P/E ratio of -0.33 and a beta of 0.62. Sintx Technologies has a twelve month low of $1.40 and a twelve month high of $6.78.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on SINT shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. Maxim Group reissued a “buy” rating and set a $6.00 price objective on shares of Sintx Technologies in a report on Thursday, June 4th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $10.00 target price on shares of Sintx Technologies in a report on Wednesday, May 20th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $9.33.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Sintx Technologies stock. Geode Capital Management LLC increased its position in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 33.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,339 shares of the company’s stock after acquiring an additional 3,848 shares during the quarter. Geode Capital Management LLC owned 0.56% of Sintx Technologies worth $49,000 as of its most recent SEC filing. Institutional investors and hedge funds own 18.38% of the company’s stock.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.